Here, we investigated the mechanism underlying decreased expression of ZNF268 as well as the consequences of ZNF268 downregulation in K562 cells, a human erythroleukemia cell line derived from a patient with chronic myelogenous leukemia [26], [27], [28]. Here, ZNF268 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.